Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increased Dose of GnRH Antagonist for Coasting in IVF
NCT01109888Phase 2Withdrawn
- Sponsor
- Edith Wolfson Medical Center
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of cetrorelix in ovarian hyperstimulation syndrome (OHSS), sponsored by Edith Wolfson Medical Center. Status: withdrawn.
02
Drugs
cetrorelix
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT01109888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109888.